Our top pick for
Chico's FAS Inc is an apparel retail business based in the US. Chicos FAS shares (CHS) are listed on the NYSE and all prices are listed in US Dollars. Chicos FAS employs 4,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$5.04|
|52-week range||$1.00 - $7.06|
|50-day moving average||$4.78|
|200-day moving average||$5.01|
|Wall St. target price||$5.63|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.01|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||3.92%|
|1 month (2021-09-24)||3.07%|
|3 months (2021-07-23)||-15.72%|
|6 months (2021-04-23)||69.13%|
|1 year (2020-10-23)||320.00%|
|2 years (2019-10-25)||41.97%|
|3 years (2018-10-25)||7.82|
|5 years (2016-10-25)||12.07|
Valuing Chicos FAS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Chicos FAS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Chicos FAS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.86. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Chicos FAS's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Chicos FAS's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $36.5 million.
The EBITDA is a measure of a Chicos FAS's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.6 billion|
|Gross profit TTM||$263.7 million|
|Return on assets TTM||-4.67%|
|Return on equity TTM||-48.67%|
|Market capitalisation||$617.2 million|
TTM: trailing 12 months
There are currently 10.9 million Chicos FAS shares held short by investors – that's known as Chicos FAS's "short interest". This figure is 32.1% up from 8.2 million last month.
There are a few different ways that this level of interest in shorting Chicos FAS shares can be evaluated.
Chicos FAS's "short interest ratio" (SIR) is the quantity of Chicos FAS shares currently shorted divided by the average quantity of Chicos FAS shares traded daily (recently around 2.3 million). Chicos FAS's SIR currently stands at 4.83. In other words for every 100,000 Chicos FAS shares traded daily on the market, roughly 4830 shares are currently held short.
However Chicos FAS's short interest can also be evaluated against the total number of Chicos FAS shares, or, against the total number of tradable Chicos FAS shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chicos FAS's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Chicos FAS shares in existence, roughly 90 shares are currently held short) or 0.108% of the tradable shares (for every 100,000 tradable Chicos FAS shares, roughly 108 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chicos FAS.
Find out more about how you can short Chicos FAS stock.
We're not expecting Chicos FAS to pay a dividend over the next 12 months.
Chicos FAS's shares were split on a 2:1 basis on 22 February 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Chicos FAS shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Chicos FAS shares which in turn could have impacted Chicos FAS's share price.
Over the last 12 months, Chicos FAS's shares have ranged in value from as little as $1 up to $7.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Chicos FAS's is 1.5815. This would suggest that Chicos FAS's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Chico's FAS, Inc. operates as an omnichannel specialty retailer of women's private branded casual-to-dressy clothing, intimates, and complementary accessories. It operates under the Chico's, White House Black Market (WHBM), Soma, and TellTale brands. The Chico's brand primarily sells private branded clothing focusing on women 45 and older. The WHBM brand sells everyday basics and denim, polished casual apparel, relaxed workwear, black and white pieces, feminine all-occasion dresses, shoes, belts, scarves, handbags, and jewelry for women 35 and older. The Soma brand sells private branded lingerie, sleepwear, and loungewear products. The TellTale brand sells private branded lingerie products.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.